P&G sells prescription drug unit

Proctor & Gamble has agreed to sell its prescription drug business for $3.1 billion to the Irish pharmaceutical firm Warner Chilcott.  School of Law Professor Kevin Outterson, an authority in pharma law and marketing, says the deal is evidence of further consolidation in the prescription drug industry.

“P&G evidently decided they couldn’t compete at at scale with only $2.3 billioin in annual revenues.”

Contact Kevin Outterson, 617-353-3130, mko@bu.edu

Post a Comment

Your email address is never shared. Required fields are marked *